Multiple Myelomas News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Multiple Myeloma Research Focusing on Combinations, Sequencing - Targeted Oncology



Targeted Oncology
 
Multiple Myeloma Research Focusing on Combinations, Sequencing 
Targeted Oncology
Waxman: We discussed early relapse therapies, the many new treatments, and important randomized phase III trials for patients with multiple myeloma. We focused on second- generation proteasome inhibitors, such as carfilzomib and ixazomib, as well as ...

 


Understanding Genetic Abnormalities Key to Improving Multiple Myeloma Outcomes - Targeted Oncology



Targeted Oncology
 
Understanding Genetic Abnormalities Key to Improving Multiple Myeloma Outcomes 
Targeted Oncology
?Over the years as we have understood the biology of this disease better, it has become more clear that myeloma is not just 1 disease, and as multiple myeloma has become richer, so to speak, the divide between the rich and the poor has become even ...

and more » 


Genomic Sequencing Identifies Actionable Mutations in 75% of Patients With Multiple Myeloma - Journal of Clinical Pathways



Genomic Sequencing Identifies Actionable Mutations in 75% of Patients With Multiple Myeloma 
Journal of Clinical Pathways
A recent study found that a significant number of patients with multiple myeloma harbor potentially actionable oncogenic molecular alterations, prompting a need for novel precision medicine approaches. The study will be presented at the 59th Annual ...

 


Medical Affairs Reputations: Multiple Myeloma (EU5) 2016 - PR Newswire (press release)



Medical Affairs Reputations: Multiple Myeloma (EU5) 2016 
PR Newswire (press release)
We surveyed 150 EU5 oncologists and haematologists to compare the medical affairs teams for seven multiple myeloma treatments. Results show stiff competition across the pack, with two teams neck and neck for top spot and another three battling to rule ...

and more » 


PFS Superior in Multiple Myeloma With Less Frequent, Higher Dose Carfilzomib - Targeted Oncology



Targeted Oncology
 
PFS Superior in Multiple Myeloma With Less Frequent, Higher Dose Carfilzomib 
Targeted Oncology
Progression-free survival (PFS) was extended by 3.6 months with higher-dose, once-weekly carfilzomib (Kyprolis) compared with a lower-dose, twice-weekly regimen in patients with relapsed/refractory multiple myeloma, according to according to phase III ...

 


FDA Grants BCMA CAR T-Cell Therapy Breakthrough Designation in Myeloma - OncLive



FDA Grants BCMA CAR T-Cell Therapy Breakthrough Designation in Myeloma 
OncLive
The FDA has granted bb2121 a breakthrough therapy designation for previously treated patients with relapsed/refractory multiple myeloma, according to Celgene Corporation and bluebird bio, the companies developing the anti?B-cell maturation antigen ...

 


EMA and FDA realize promise of CAR-T therapy in multiple myeloma - The Pharma Letter



EMA and FDA realize promise of CAR-T therapy in multiple myeloma 
The Pharma Letter
A CAR-T therapy targeting b-cell maturation antigen (BCMA) in previously treated patients with multiple myeloma, has been granted breakthrough therapy designation by the US Food and Drug Administration (FDA) and PRIME eligibility by the European ...

and more » 


Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017 - PR Newswire (press release)



Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017 
PR Newswire (press release)
The report provides insights into Multiple Myeloma epidemiology, Multiple Myeloma diagnosed patients, and Multiple Myeloma treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Multiple Myeloma ...

and more » 


Multiple Myeloma Support Group helps patients and families - The Chronicle



The Chronicle
 
Multiple Myeloma Support Group helps patients and families 
The Chronicle
The group meets from 10 a.m. to noon on the third Monday of each month in the Orange County Department of Mental Health, 30 Harriman Drive, Goshen, N.Y. It is run by and for Myeloma patients and operates in affiliation with the International Myeloma ...

 


A new option for high-risk multiple myeloma? - Fred Hutch News Service



Fred Hutch News Service
 
A new option for high-risk multiple myeloma? 
Fred Hutch News Service
?The management of multiple myeloma is becoming more and more complex as we understand the subtleties of the disease. We're trying to better tailor treatment for those nuances,? Green said. ?At academic centers such as ours, we have the luxury of being ...